Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Waiting for a Sharp Increase in Prostate Cancer Cases.

2.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

3.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

4.

Which Risk Model Better Identifies High-Risk Smoldering MM?

5.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot